Biotron Limited (BIT.AX) - Stock Prices, Stock Peers & Analysis

Home
BIT.AX

Company Name	Biotron Limited
Symbol	BIT.AX
Currency	AUD
Price	0.018
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	16,242,894
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.016 - 0.12
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Michelle Miller BSc., GCertAppFin, MSc., Ph.D.
Website	https://www.biotron.com.au

An error occurred while fetching data.

About Biotron Limited

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in